Authors: | Korde, N.; Mastey, D.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Tavitian, E.; Salcedo, M.; Sams, A.; Diab, V.; Chung, D. J.; Scordo, M.; Lahoud, O. B.; Landau, H. J.; Arcila, M. E.; Giralt, S.; Ho, C.; Roshal, M.; Devlin, S. M.; Dogan, A.; Landgren, O. |
Abstract Title: | MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone |
Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
Journal Title: | Blood |
Volume: | 132 |
Issue: | Suppl. 1 |
Meeting Dates: | 2018 Dec 1-4 |
Meeting Location: | San Diego, CA |
ISSN: | 0006-4971 |
Publisher: | American Society of Hematology |
Date Published: | 2018-11-29 |
Language: | English |
ACCESSION: | WOS:000454837605311 |
PROVIDER: | wos |
DOI: | 10.1182/blood-2018-99-117120 |
Notes: | Meeting Abstract: 1983 -- Source: Wos |